Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 466,000 shares, a drop of 15.9% from the February 28th total of 554,100 shares. Based on an average trading volume of 320,500 shares, the days-to-cover ratio is […]
HC Wainwright reaffirmed their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. They currently have a $7.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other research firms have also […]